Dr. Wells is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St
# Wright
Philadelphia, PA 19104Phone+1 215-662-8900Fax+1 215-243-3222
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1990 - 1993
- Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1989
- Johns Hopkins University School of MedicineClass of 1987
Certifications & Licensure
- PA State Medical License 2002 - 2024
- CT State Medical License 1998 - 2003
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- Non-drug Interventions for Migraines Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- 485 citationsMatrix Stiffness Modulates Proliferation, Chemotherapeutic Response and Dormancy in Hepatocellular Carcinoma CellsJoerg Schrader, Timothy T. Gordon-Walker, Rebecca L. Aucott, Marielle Van Deemter, Alexander Quaas
Hepatology. 2011-04-01 - 353 citationsRobust cellular reprogramming occurs spontaneously during liver regenerationKilangsungla Yanger, Yiwei Zong, Lara R. Maggs, Suzanne N. Shapira, Ravi Maddipati
Genes & Development. 2013-04-01 - 77 citationsNormal and Fibrotic Rat Livers Demonstrate Shear Strain Softening and Compression Stiffening: A Model for Soft Tissue Mechanics.Maryna Perepelyuk, Likang Chin, Xuan Cao, Anne van Oosten, Vivek B. Shenoy
Plos One. 2016-01-06
Press Mentions
- Penn Team Creates First Bile Duct-on-A-chip, Replicating the Structure and Cellular Makeup of the TissueOctober 2nd, 2019
- The Medical Device Behind the Discovery of a New Human StructureApril 13th, 2018
- Novel Biomarkers May Provide Guide to Personalized Hepatitis C TherapyMay 13th, 2015
- Join now to see all
Grant Support
- Mechanisms Of Fibrosis In Pediatric Liver DiseasesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Isolation, Identification And Characterization Of A Toxin Causing Biliary AtresiaNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Tgf-Beta, Matrix, And Myofibroblasts In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Betaglycan As A Modulator Of Tgf-Beta Signaling In HepatomaNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
- Betaglycan As A Modulator Of Tgf-B Signaling In HepatomaNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2006
- Tgf-B Mediated Fibrosis In A Hepatic Stellate Cell ModelNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2005
- Tgf-B Mediated Fibrosis In A Hepatic Stellate Cell ModelNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
- TGF Beta Receptor StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases1999
- Oligomerization And Folding Of Membrane ProteinsNational Institute Of Diabetes And Digestive And Kidney Diseases1998–1999
- Oligomerization And Folding Of Membrane ProteinsNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
- Cloning Na+-Contransporters By Selective AmplificationNational Institute Of Diabetes And Digestive And Kidney Diseases1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: